Collaborative team
The clinical trial was achieved by the extraordinary collaboration of university researchers, hearing scientists, engineers, clinicians and clinical trial specialists from UNSW, University of Sydney, Melbourne University & the Bionics Institute, Macquarie University, NextSense and international collaborators.
The cochlear implant gene delivery device was developed by industry partner Cochlear Ltd working with the UNSW BaDGE team and the programme was principally funded by the National Health and Medical Research Council (NHMRC) Development Grant and the Passe & Williams Foundation.
The trial was successful because of the extraordinary support of the clinical trial participants, who had confidence in the science and the team which built the study, and generously contributed their time by attending the many follow-up visits to the Macquarie University hearing hub in the year following their surgery.
CINGT Operational Team
The CINGT team consists of the following members:
 |
 |
 |
 |
 |
Prof. Gary Housley UNSW Sydney Translational Neuroscience Facility (Director) & Chair of Physiology, School of Medical Sciences Program Lead Chief Investigator |
Cln Prof. Catherine Birman University of Sydney & NextSense - Director Program Lead Clinical Investigator |
Prof. Catherine McMahon Macquarie University Hearing Hub, Head of Audiology Program Lead Audiology |
Mayryl Duxbury UNSW Sydney Translational Neuroscience Facility Clinical Trial Manager |
Dr. Fadwa Al Nafjan Macquarie University Hearing Hub Clinical Trial Audiologist |
 |
 |
 |
 |
 |
Dr. WaiKong Lai NextSense Biomedical Engineer Investigator |
Prof. Nigel Lovell UNSW Sydney Graduate School of Biomedical Engineering (Head and Institute Director) Investigator |
Prof. David McAlpine Macquarie University Hearing Hub, Head of Hearing Sciences Investigator |
Dr. Jeremy Pinyon UNSW Sydney Translational Neuroscience Facility, School of Medical Sciences Investigator |
Adj. A/Prof. Matthias Klugmann UNSW Sydney Translational Neuroscience Facility, School of Medical Sciences Macquarie University Hearing Hub Investigator |
 |
 |
 |
 |
 |
Prof. Robert Shepherd Bionics Institute & Univ. Melbourne Investigator |
A/Prof. James Fallon Bionics Institute & Univ. Melbourne Investigator |
A/Prof. Andrew Wise Bionics Institute & Univ. Melbourne Investigator |
Prof. Daniel Scherman Université Paris Descartes, Sorbonne-Paris-Cité, Paris, France, CNRS Investigator - International |
Dr. Corinne Marie Université Paris Descartes, Sorbonne-Paris-Cité, Paris, France, CNRS Investigator - International |
 |
 |
 |
 |
 |
Prof. Anne Schilder Ear Institute, University College London, United Kingdom; HIHR UCLH Biomedical Research Centre Operations Collaborator - International |
Prof. Jim Patrick, AO Chief Scientist - Emeritus, Cochlear Ltd (consultant) Investigator |
Prof. Paul Carter Cochlear Ltd, Senior Principal Scientist Investigator |
Ya Lang Enke Cochlear Ltd, Senior Research Engineer and Product Development Investigator |
Dr Robert Gay Cochlear Ltd, Director Pharmaceutical Approaches Investigator |
 |
 |
 |
 |
 |
Mr. Edward Crawford UNSW Sydney, School of Medical Sciences Electronics Engineer |
Dr. Georg von Jonquieres UNSW Sydney Translational Neuroscience Facility, School of Medical Sciences - molecular neuroscience |
Dr. Amr Al Abed UNSW Sydney, Graduate School of Biomedical Engineering - Research Associate Bionics Engineer |
Dr. Cherylea Browne UNSW Sydney Translational Neuroscience Facility & Dept. Physiology, School of Medical Sciences (conjoint lecturer in neuroscience). |
Dr. Jaime Undurraga Macquarie University Hearing Hub Cochlear Implant Electrophysiologist |
 |
 |
|||
Saji Maruthurkkara Macquarie University Hearing Hub Clinical Trial Audiologist |
Ms Rachelle Hassarati NextSense Clinical Trials Operations |
Dr. Halit Sanli NextSense Principal Hospital Scientist |
Data and Safety Monitoring Board
The Data and Safety Monitoring Board consists of the following members.
 |
 |
 |
|
Prof. David Ryugo Hearing Research Laboratory Head, Garvan Institute, Sydney Program Lead Chief Investigator |
Prof. Wiliam Gibson Emeritus Prof. Otolaryngology, University of Sydney DSMB Clinical Advisor |
Dr. Lisa Nelson Scientia Clinical Research CEO, UNSW Sydney DSMB Clinical Trials Advisor |
Dr. Mark Donoghue UNSW Sydney Biostatistician DSMB Biostatistics |
Grants
Supported with grants from:
- Australian Research Council (ARC LP0992098, ARC LP140101008)
- National Health and Medical Research Council (APP 1091646, and APP 1122055)
- Collaborative research funding from Industry partner Cochlear Ltd and the Cochlear - Macquarie University Alliance
- Philanthropic support from the Garnett Passe and Rodney Williams Memorial Foundation
 |
 |
Australian Research Council |
Cochlear Ltd and the Cochlear |
 |
 |
Garnett Passe & Rodney Williams Memorial Foundation |
National Health and Medical Research Council |